Tradestie Institutional Equity Comparison Engine

MLAB vs SVRE โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-17 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

MLAB Overall Edge

MLAB Captures Institutional Edge (3โ€“0 Pillars ยท 10โ€“0 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Mesa Laboratories Inc (MLAB) driven by superior Valuation, Growth & Margin, Momentum & Technical. Fundamentally, MLAB trades at 24.9x Forward P/E with 10.4% operating margin (+2.6% YoY revenue) versus SVRE at N/M Forward P/E and 0.0% operating margin (-63.0% YoY). In options structure, MLAB sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against SVRE sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner MLAB
MLAB 24.9x vs SVRE N/M Fwd P/E
Growth & Margin Winner MLAB
Op Margin 10.4% vs 0.0% ยท YoY +2.6% vs -63.0%
Momentum & Technical Winner MLAB
1Y +82.9% vs -56.7% ยท 52W Pos 88% vs 0%
Options & Structure Winner Tie
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
MLAB NASDAQ
Mesa Laboratories Inc
Industrial Instruments For Measurement, Display, And Control
$135.27
+0.88% 1D
Market Cap $781.3M
1M Return +9.7%
1Y Return +82.94%
Forward P/E 24.9x
Unified AI Score
41.6 / 100 SELL
Tech 20.0 Fund 32.0 Flow 50.0 Mom 44.0
SVRE NASDAQ
SaverOne 2014 Ltd. American Depositary Shares
Services-Computer Programming Services
$0.43
-1.46% 1D
Market Cap $1.1M
1M Return -76.25%
1Y Return -56.66%
Forward P/E N/M
Unified AI Score
39.3 / 100 SELL
Tech 25.0 Fund 46.0 Flow 50.0 Mom 59.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: MLAB +82.94% SVRE -56.66% Spread: +139.6 pp (MLAB Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
MLAB TTM Op. Margin: 10.4% SVRE TTM Op. Margin: 0.0%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on MLAB vs SVRE. Trailing 12-month operating profitability (MLAB 10.4% vs SVRE 0.0%) and valuation multiples (MLAB 24.9x vs SVRE N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: MLAB (10) vs SVRE (0)
Institutional Metric MLAB SVRE Criterion Row Winner
Market Capitalization Scale $781.3M $1.1M Larger Scale MLAB
Trailing P/E Ratio Valuation 119.8x N/M Lower Multiple MLAB
Forward P/E Ratio Valuation 24.9x N/M Lower Multiple MLAB
Revenue Growth (YoY) Growth +2.6% -63.0% Higher Growth MLAB
Operating Margin (TTM) Profitability 10.4% 0.0% Higher Margin MLAB
Net Profit Margin Profitability 2.6% 0.0% Higher Margin MLAB
Return on Equity (ROE) Capital Efficiency 3.6% -151.1% Higher ROE MLAB
52-Week Range Position Momentum 88% ($70โ€“$144) 0% ($0โ€“$6) Stronger Trend MLAB
Beta / 30D Volatility Risk Regime 1.14ฮฒ ยท 54% Vol 0.49ฮฒ ยท 190% Vol Lower Realized Risk MLAB
Unified Institutional Score Composite Signal 41.6 / 100 (SELL) 39.3 / 100 (SELL) Higher Composite MLAB

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full MLAB vs SVRE Buy Guide
MLAB UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live MLAB Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
SVRE UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live SVRE Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither MLAB nor SVRE registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.